Genoway (ALGEN) - Total Liabilities

Latest as of June 2025: €20.43 Million EUR ≈ $23.89 Million USD

Based on the latest financial reports, Genoway (ALGEN) has total liabilities worth €20.43 Million EUR (≈ $23.89 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ALGEN long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Genoway - Total Liabilities Trend (2004–2024)

This chart illustrates how Genoway's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Genoway asset portfolio.

Genoway Competitors by Total Liabilities

The table below lists competitors of Genoway ranked by their total liabilities.

Company	Country	Total Liabilities
Leviathan Gold Ltd V:LVX	Canada	CA$835.69K
Unifin Financiera S. A. B. de C. V MX:UNIFINA	Mexico	MX$83.80 Billion
Battalion Oil Corp NYSE MKT:BATL	USA	$511.94 Million
Avision Inc TW:2380	Taiwan	NT$1.93 Billion
Genus Paper & Boards Limited NSE:GENUSPAPER	India	Rs6.39 Billion
Gencurix Inc KQ:229000	Korea	₩17.10 Billion
TINYBUILD REGSCAT3 DL-001 F:8Z3	Germany	€11.50 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Genoway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Genoway's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genoway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genoway (2004–2024)

The table below shows the annual total liabilities of Genoway from 2004 to 2024.

Year	Total Liabilities	Change
2024-12-31	€13.23 Million ≈ $15.46 Million	-8.54%
2023-12-31	€14.46 Million ≈ $16.90 Million	-13.71%
2022-12-31	€16.76 Million ≈ $19.59 Million	-6.59%
2021-12-31	€17.94 Million ≈ $20.97 Million	-3.40%
2020-12-31	€18.57 Million ≈ $21.71 Million	+50.86%
2019-12-31	€12.31 Million ≈ $14.39 Million	+4.35%
2018-12-31	€11.80 Million ≈ $13.79 Million	+18.25%
2017-12-31	€9.98 Million ≈ $11.66 Million	+54.90%
2016-12-31	€6.44 Million ≈ $7.53 Million	+5.62%
2015-12-31	€6.10 Million ≈ $7.13 Million	+16.59%
2014-12-31	€5.23 Million ≈ $6.12 Million	+12.63%
2013-12-31	€4.64 Million ≈ $5.43 Million	-18.53%
2012-12-31	€5.70 Million ≈ $6.66 Million	-1.31%
2011-12-31	€5.78 Million ≈ $6.75 Million	-15.47%
2010-12-31	€6.83 Million ≈ $7.99 Million	-6.98%
2009-12-31	€7.35 Million ≈ $8.59 Million	+7.59%
2008-12-31	€6.83 Million ≈ $7.98 Million	+19.20%
2007-12-31	€5.73 Million ≈ $6.70 Million	-17.87%
2006-12-31	€6.97 Million ≈ $8.15 Million	+16.76%
2005-12-31	€5.97 Million ≈ $6.98 Million	+69.98%
2004-12-31	€3.51 Million ≈ $4.11 Million	--

About Genoway

PA:ALGEN France Biotechnology

Market Cap

$35.20 Million

€30.11 Million EUR

Market Cap Rank

#23733 Global

#371 in France

Share Price

€2.44

Change (1 day)

+2.95%

52-Week Range

€2.10 - €3.18

All Time High

€5.54